• 1. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
• 4. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

Professional Introduction to 7-Bromo-1H-indazole-3-carboxylic acid (CAS No. 885278-71-7)

7-Bromo-1H-indazole-3-carboxylic acid, identified by the Chemical Abstracts Service Number (CAS No.) 885278-71-7, is a significant intermediate in modern pharmaceutical and chemical synthesis. This compound belongs to the indazole family, a heterocyclic aromatic structure that has garnered considerable attention in medicinal chemistry due to its versatile biological activities and synthetic potential.

The molecular framework of 7-Bromo-1H-indazole-3-carboxylic acid consists of a brominated indazole core, which is functionalized with a carboxylic acid group at the 3-position. This structural motif makes it a valuable building block for the development of novel therapeutic agents. The presence of the bromine atom at the 7-position enhances its reactivity, allowing for further functionalization via cross-coupling reactions such as Suzuki-Miyaura, Buchwald-Hartwig, and other palladium-catalyzed transformations.

In recent years, 7-Bromo-1H-indazole-3-carboxylic acid has been extensively studied for its role in synthesizing biologically active molecules. One of the most notable applications is in the development of anticancer agents. Indazole derivatives have demonstrated promising activity against various cancer types by inhibiting key enzymes and pathways involved in tumor growth and progression. The carboxylic acid moiety provides a handle for further derivatization, enabling the creation of prodrugs or conjugates that enhance drug delivery and bioavailability.

Moreover, 7-Bromo-1H-indazole-3-carboxylic acid has found utility in the synthesis of small-molecule inhibitors targeting bacterial resistance mechanisms. The indazole scaffold is known to interact with bacterial enzymes, disrupting essential metabolic pathways. Researchers have leveraged this property to design compounds that exhibit potent antibacterial activity, particularly against multidrug-resistant strains. The bromine substituent facilitates modifications that improve binding affinity and selectivity, making it an indispensable tool in antibiotic discovery.

Recent advancements in computational chemistry have further highlighted the significance of 7-Bromo-1H-indazole-3-carboxylic acid. Molecular modeling studies have revealed its potential as a scaffold for kinase inhibitors, which are critical in treating diseases such as leukemia and rheumatoid arthritis. By integrating machine learning algorithms with traditional pharmacophore modeling, scientists have been able to predict novel derivatives of 7-Bromo-1H-indazole-3-carboxylic acid with enhanced pharmacological properties.

The versatility of 7-Bromo-1H-indazole-3-carboxylic acid extends beyond oncology and antibacterial applications. It has been explored in the development of neuroprotective agents, where indazole derivatives show promise in mitigating neurodegenerative diseases like Alzheimer's and Parkinson's. The carboxylic acid group enables conjugation with neurotrophic factors or other bioactive molecules, potentially leading to treatments that slow disease progression.

In conclusion, 7-Bromo-1H-indazole-3-carboxylic acid (CAS No. 885278-71-7) represents a cornerstone in pharmaceutical research due to its structural adaptability and biological relevance. Its role in synthesizing high-value intermediates for therapeutic applications underscores its importance in drug discovery pipelines. As research continues to uncover new synthetic pathways and biological targets, the utility of this compound is expected to expand, solidifying its position as a key player in modern medicinal chemistry.

• 660823-36-9(6-Bromo-1H-indazole-3-carboxylic acid)
• 4498-67-3(Indazole-3-carboxylic acid)
• 78155-74-5(Methyl 5-bromo-1H-indazole-3-carboxylate)
• 885279-52-7(Methyl 7-bromo-1H-indazole-3-carboxylate)
• 885521-80-2(4-Bromo-1H-indazole-3-carboxylic acid)
• 885518-30-9(4,6-Dibromo-1H-indazole-3-carboxylic acid)
• 887576-89-8(7-BROMO-1H-INDAZOLE-3-CARBALDEHYDE)
• 885279-56-1(Ethyl 7-bromo-1H-indazole-3-carboxylate)
• 1077-94-7(5-Bromo-1H-indazole-3-carboxylic Acid)
• 885278-42-2(Methyl 6-bromo-1H-indazole-3-carboxylate)